Home » ADVENT TO SELL GERMAN PHARMACEUTICAL GROUP VIATRIS TO MEDA
ADVENT TO SELL GERMAN PHARMACEUTICAL GROUP VIATRIS TO MEDA
Advent International has agreed to sell German pharmaceutical group Viatris to Swedish specialty pharma company Meda for €750m.Viatris has operations through its own affiliates in 14 countries with a strong focus on larger European markets. The company's most important therapeutic area is respiratory. It also has a strong position in the therapeutic area of pain/inflammation, which is a core therapeutic area for Meda.
AltAssets (http://www.altassets.com/news/arc/2005/nz7319.php)
KEYWORDS FDAnews Drug Daily Bulletin
Upcoming Events
-
23Apr
-
25Apr
-
07May
-
14May
-
30May